Specific humoral immune response and XBB variants re-infection risk of hemodialysis patients after Omicron BA.5 infection in China

Currently, there is limited understanding of the specific humoral immune response in BA.5-infected hemodialysis patients (BA.5-CHDPs) with previous COVID-19 vaccination. Additionally, the relevant risk factors for reinfection with XBB variants in BA.5-CHDPs have yet to be elucidated.